Article

December 2, 2011

Dr. Joshua Bershad Discusses RWJUH's Approach to Achieving Value and Management Techniques

Dr. Joshua Bershad, Senior Vice President, Medical Affairs and Chief Medical Officer at Robert Wood Johnson University Hospital, New Brunswick, NJ, discusses the success RWJUH has experienced by focusing on the multi-pronged benefits of achieving value--better care, lower cost, improved outcomes, reducing readmission and emergency room visits.

In addition to realizing the benefits from making value a priority, Dr. Bershad says another imperative aspect to managed care is to eliminate waste from the process by utilizing management techniques, such as Lean Six Sigma, which has proved effective for RWJUH.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos

Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center

Merrill H. Stewart, MD

Dr Carrie Kitko

Jeffrey Fitzgerald, JD

Dr Carrie Kitko

Related Content

Constantine Farmakidis, MD | Image Credit: University of Kansas Medical Center

July 3rd 2025

A Closer Look at Nipocalimab’s Impact on Myasthenia Gravis Care: Constantine Farmakidis, MD

Maggie L. Shaw Constantine Farmakidis, MD

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved patient outcomes across diverse populations.

Managed Care Cast

July 1st 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

Richard J. Nowak, MD, MS | Image Credit: Yale School of Medicine

June 24th 2025

Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS

Maggie L. Shaw Richard J. Nowak, MD, MS

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.

Managed Care Cast

June 24th 2025

Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care

Giuliana Grossi Skylar Jeremias Eva Szigethy, MD, PhD Benjamin Cohen, MD

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.

Hamlet Gasoyan, PhD

June 19th 2025

Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD

Hayden E. Klein Hamlet Gasoyan, PhD

Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.

Image credit: Yale School of Medicine

June 19th 2025

Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

Julia Bonavitacola Onyema Ogbuagu, MBBCh, FACP, FIDSA

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted.

Related Content

Constantine Farmakidis, MD | Image Credit: University of Kansas Medical Center

July 3rd 2025

A Closer Look at Nipocalimab’s Impact on Myasthenia Gravis Care: Constantine Farmakidis, MD

Maggie L. Shaw Constantine Farmakidis, MD

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved patient outcomes across diverse populations.

Managed Care Cast

July 1st 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

Richard J. Nowak, MD, MS | Image Credit: Yale School of Medicine

June 24th 2025

Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS

Maggie L. Shaw Richard J. Nowak, MD, MS

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.

Managed Care Cast

June 24th 2025

Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care

Giuliana Grossi Skylar Jeremias Eva Szigethy, MD, PhD Benjamin Cohen, MD

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.

Hamlet Gasoyan, PhD

June 19th 2025

Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD

Hayden E. Klein Hamlet Gasoyan, PhD

Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.

Image credit: Yale School of Medicine

June 19th 2025

Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

Julia Bonavitacola Onyema Ogbuagu, MBBCh, FACP, FIDSA

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions